These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23763720)

  • 1. Are C-reactive protein and ferritin levels being overlooked in indigenous australians with chronic kidney disease?
    Claes J; Ellis JA; Rettie F; Butcher B; Bradley J
    J Ren Care; 2013 Sep; 39(3):176-81. PubMed ID: 23763720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are haemoglobin levels adequate in patients with chronic kidney disease (CKD) stage 2-4?
    Trowbridge L; Kruger A; Arnold A; Butcher B; Bradley J
    J Ren Care; 2013 Dec; 39(4):194-9. PubMed ID: 23782818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do iron guidelines translate into good clinical practice for patients on haemodialysis?
    Morris M; Snedeker M; Reed G; Butcher B; Bradley J
    J Ren Care; 2014 Mar; 40(1):49-54. PubMed ID: 24588980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease in indigenous Australians: a disease of disadvantage.
    Cass A; Cunningham J; Snelling P; Wang Z; Hoy W
    Ethn Dis; 2002; 12(3):373-8. PubMed ID: 12148708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
    Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National haemodialysis guidelines: an assessment of compliance from 2001-2003.
    Bannister KM; Snelling P;
    Nephrology (Carlton); 2006 Apr; 11(2):90-6. PubMed ID: 16669967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
    Kalender B; Ozdemir AC; Koroglu G
    Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin and iron deficiency in pre-kidney transplant patients.
    Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
    Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
    Yong K; Kairaitis L
    Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment.
    Preston-Thomas A; Cass A; O'Rourke P
    Aust N Z J Public Health; 2007 Oct; 31(5):419-21. PubMed ID: 17931287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary syndromes in indigenous Australians: opportunities for improving outcomes across the continuum of care.
    Brown A
    Heart Lung Circ; 2010; 19(5-6):325-36. PubMed ID: 20363187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal biopsy findings among Indigenous Australians: a nationwide review.
    Hoy WE; Samuel T; Mott SA; Kincaid-Smith PS; Fogo AB; Dowling JP; Hughson MD; Sinniah R; Pugsley DJ; Kirubakaran MG; Douglas-Denton RN; Bertram JF
    Kidney Int; 2012 Dec; 82(12):1321-31. PubMed ID: 22932120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of hookworm infection, iron deficiency and anaemia in an aboriginal community in north-west Australia.
    Hopkins RM; Gracey MS; Hobbs RP; Spargo RM; Yates M; Thompson RC
    Med J Aust; 1997 Mar; 166(5):241-4. PubMed ID: 9076267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians.
    McKercher C; Jose MD; Grace B; Clayton PA; Walter M
    Aust N Z J Public Health; 2017 Feb; 41(1):15-20. PubMed ID: 27960225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocyte indices in patients with end stage renal disease on hemodialysis.
    Bhandari S; Turney JH; Brownjohn AM; Norfolk D
    J Nephrol; 1998; 11(2):78-82. PubMed ID: 9589378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.